Comparative Effectiveness of Tofacitinib Versus Ustekinumab and Vedolizumab among Ulcerative Colitis Patients With Prior Anti- Tumor Necrosis Factor (TNF) Failure

23/02/2022
23/04/2024
EU PAS number:
EUPAS45035
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

A3921415 Non Interventional Study Protocol Final 08Feb2022_Redacted

English (1.87 MB - PDF) View document
Updated protocol

A3921415 Non Interventional Study Protocol Amendment 1 (clean) 08Apr2022 (1)_Redacted

First published: 22/02/2024
English (1.98 MB - PDF) View document
Study results
Study results

A3921415 Non Interventional Study Report Abstract 22 December 2022_Redacted

English (1.54 MB - PDF) View document
Study report
Study report

A3921415 Non Interventional Study Report 22 December 2022_Redacted

English (4.08 MB - PDF) View document
Other information
Study, other information

A3921415 Non Interventional Study Abstract_Amendment 1 08Apr2022_Redacted

English (1.7 MB - PDF) View document

A3921415 Non Interventional Study Abstract_Final 08Feb2022_Redacted

English (1.7 MB - PDF) View document